Phase II Study of Antineoplastons A10 and AS2-1 Infusions in Children With Visual Pathway Glioma

Trial Profile

Phase II Study of Antineoplastons A10 and AS2-1 Infusions in Children With Visual Pathway Glioma

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 May 2009 According to a Burzynski Research media release, the FDA responded to the questions in the Briefing Package and thereafter cancelled the meeting on May 7, 2009.
    • 07 May 2009 Interim results in 16 patients reported in a Burzynski Research media release.
    • 07 May 2009 According to a Burzynski Research media release, results have been presented to the FDA in the Request for End of Phase II Meeting Briefing Package to be discussed at a meeting with the FDA on May 7, 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top